ArticleClinical ophthalmology (Auckland, N.Z.)2024

Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration.

Asako Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.